No Signs of the DOJ Letting Off the Pedal with Medicare Fraud Investigations
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
The decision deepens a split among circuit courts regarding how to determine liability for false claims
The 15-minute assay to detect sepsis and assess its severity and risk is expected to get full FDA approval by 2026
Regulatory expert Julie Ballard shares her thoughts on the most useful resources for labs as they get ready to comply with Stage 1
Sara Pirzadeh-Miller offers advice on overcoming the reimbursement barriers genetic counselors face in the clinical lab and beyond
Revenue cycle management leaders provide their thoughts on how lab leaders may want to proceed when it comes to POC tests
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications
Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025